Product: Ramipril Capsules USP 2.5 mg, a) 90 count (NDC 68180-589-09), b) 100 count NDC 68180-589-01), and c) 500 count (NDC 68180-589-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India
Reason for recall: CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Recall initiated: 20241023
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated